Application 208055

Type
ANDA
Sponsor
TORRENT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LURASIDONE HYDROCHLORIDELURASIDONE HYDROCHLORIDETABLET;ORAL20MGNoNo
002LURASIDONE HYDROCHLORIDELURASIDONE HYDROCHLORIDETABLET;ORAL40MGNoNo
003LURASIDONE HYDROCHLORIDELURASIDONE HYDROCHLORIDETABLET;ORAL80MGNoNo
004LURASIDONE HYDROCHLORIDELURASIDONE HYDROCHLORIDETABLET;ORAL120MGNoNo
005LURASIDONE HYDROCHLORIDELURASIDONE HYDROCHLORIDETABLET;ORAL60MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13668-464Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-464Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-465Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-465Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-466Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-466Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-467Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent
13668-467Lurasidone HydrochlorideLurasidone HydrochlorideTorrent Pharmaceuticals LimitedANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
55948ORIG2018-10-15